Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

NCT00363831 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Neoplasms

Interventions

DRUG: Oxaliplatin

Sponsor

The University of Hong Kong